cysteine has been researched along with Demyelinating Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tonkin, EG; Valentine, HL; Valentine, WM; Zimmerman, LJ | 1 |
| Ammar, N; Amouri, R; Barisić, N; Ceuterick, C; De Jonghe, P; Hentati, F; Martin, JJ; Merlini, L; Nelis, E; Timmerman, V | 1 |
| Filbin, MT; Zhang, K | 1 |
| Abrous, ND; Arnason, BG; Boullerne, AI; Brochet, B; Jensen, MA; Le Moal, M; Mayo, W; Petry, KG; Pua, JR; Rodriguez, JJ; Schmidt, S; Touil, T | 1 |
4 other study(ies) available for cysteine and Demyelinating Diseases
| Article | Year |
|---|---|
Parenteral N,N-diethyldithiocarbamate produces segmental demyelination in the rat that is not dependent on cysteine carbamylation.
Topics: Animals; Body Weight; Chelating Agents; Chromatography, High Pressure Liquid; Cysteine; Demyelinating Diseases; Ditiocarb; Globins; Infusion Pumps, Implantable; Infusions, Parenteral; Male; Neurofilament Proteins; Peripheral Nerves; Rats; Rats, Sprague-Dawley | 2003 |
Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.
Topics: Alleles; Arginine; Charcot-Marie-Tooth Disease; Cysteine; Demyelinating Diseases; DNA Mutational Analysis; Electrophysiology; Family Health; Female; Genetic Predisposition to Disease; Glycine; Histidine; Humans; Male; Microscopy, Electron; Mutation; Nerve Tissue Proteins; Neural Conduction; Pedigree; Peripheral Nerves; Sequence Analysis, DNA; Tryptophan | 2003 |
Myelin Po protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type Po.
Topics: Animals; Cell Adhesion Molecules; CHO Cells; Cloning, Molecular; Cricetinae; Cysteine; Demyelinating Diseases; Enzyme-Linked Immunosorbent Assay; Extracellular Space; Genes, Dominant; Molecular Weight; Mutation; Myelin P0 Protein | 1998 |
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Topics: Animals; Antibody Specificity; Autoantibodies; Biomarkers; Cysteine; Demyelinating Diseases; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Immunoglobulin M; Multiple Sclerosis; Myelin Basic Protein; Nitroso Compounds; Peptide Fragments; Predictive Value of Tests; Rats; Rats, Inbred Lew; Recurrence; Remission, Spontaneous; S-Nitrosothiols; Serum Albumin, Bovine; Spinal Cord | 2002 |